The PAN Foundation today is proud to expand access to financial assistance for people living with chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, and graft vs host disease, offering up to $3,250 per year to patients with any type of health insurance.
Previously the funding, which helps eligible patients pay for out-of-pocket deductible, copay, and coinsurance costs, was available to patients with Medicare insurance only.
“We are thrilled to expand access to care by expanding the eligibility criteria for these three funds, so they are available to more people in need,” said PAN Foundation President and CEO Kevin L. Hagan. “We continually evaluate our programs to ensure that we are doing the greatest amount of good for the people we serve. Any day we can help more people in need is a great day.”
Patients who qualify can receive up to $3,250 in financial assistance to pay for the deductibles, copays, and coinsurance costs associated with their treatment for chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, or graft vs host disease. Read More >
The Patient Access Network Foundation™ is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Partnering with generous donors, healthcare providers and pharmacies, PAN provides the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. We also work to educate policymakers about the long-term solutions needed to improve healthcare access, affordability, and equity for all. Since our founding in 2004, we have provided more than one million underinsured patients with $4 billion in financial assistance.
